Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

UNKNOWN 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2936Neoplasms 174Lung Neoplasms 149Prostatic Neoplasms 116Ovarian Neoplasms 113Colorectal Neoplasms 106Triple Negative Breast Neoplasms 98Colonic Neoplasms 91Neoplasm Metastasis 74Melanoma 66Carcinoma, Non-Small-Cell Lung 64Pancreatic Neoplasms 63Carcinoma, Intraductal, Noninfiltrating 60Stomach Neoplasms 54Head and Neck Neoplasms 47Breast Cancer Female 45Lymphedema 42Uterine Cervical Neoplasms 40Breast Carcinoma In Situ 35Esophageal Neoplasms 34Cardiotoxicity 34Urinary Bladder Neoplasms 33Motor Activity 33Lymphoma 33Endometrial Neoplasms 33Breast Diseases 33Fatigue 30Rectal Neoplasms 28Breast Neoplasms, Male 28Multiple Myeloma 27

Interventions

palbociclib 1Fulvestrant 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Hormone Receptor Positive Advanced Breast Cancer × Breast × Clear all
NCT05000736 2022-04-29

CAPACITY

ChineseAMS

Unknown
600 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

NCT05343117 2022-04-26

Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

ChineseAMS

Unknown
400 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡